drugset / Trial / NCT01241110

To Compare Ofloxacin With Azitromycin for Pelvic Inflammatory Disease (PID) Treatment

NCT01241110

Phase 4 Completed 100 enrolled Guilan University of Medical Sciences
RandomizedParallel-groupOpen-labelTreatment

Summary

Objective: To compare two oral treatments: Ofloxacin + Metronidazole, and Azitromycin +Metronidazole in outpatients with Pelvic Inflammatory Disease. Materials and Methods: Two hundred patients divided to two groups( A , B). Group A (treated by Ofloxacin 400 mg. + Metronidazole 500mg) and Group B (a single dose of oral Azitromicine 1gr + Metronidazole 500mg) for 10 days, were compared in terms of side effects and efficacy

Timeline

Start
2010-01
Primary completion
2010-08
Completion
2010-09

Drugs

EvaluationDrugModalityDoseRoute
Comparator AZITROMYCIN Unknown 1 g Oral
Comparator Ofloxacin Small molecule 400 mg Oral
Comparator Metronidazole Small molecule 500 mg Oral